Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Antibodies used were as follows: FoxO3a (Cell Signaling Technology, #12829), phospho-FoxO3a (Ser253) (HUABIO, ST49-01), Atrogin-1 (Proteintech, 67172-1-Ig, RRID: AB_2882468), MuRF-1 (Proteintech, 55456-1-AP, RRID: AB_11182630), GAPDH (Proteintech, 60004-1-Ig, RRID: AB_2107436), and HRP-conjugated secondary antibodies (Proteintech, SA00001-1/SA00001-2)
Following oral administration, Drug A is 100 % absorbed but 40 % bioavailable, while Drug B is 80 % absorbed and 60 % bioavailable
In our study, FOXO4-DRI was found to effectively promote apoptosis in senescent cells by blocking the FOXO4-P53 interaction and facilitating P53 phosphorylation
| 07.09.26 | 13 min read
moving air introduces contaminants
If your results show a mild deficiency and your GP confirms you dont have absorption issues, you can then try a high-dose sublingual spray for 3 months and re-test
US$ 26.46
US$ 29.46
US$ 25.13
